Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
Closed Posted
- Opportunity number
- PAR-25-039
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Independent School Districts
- Public or Indian Housing Auth.
- County Governments
- State Governments
- Tribal Organizations (Not Federally Recognized)
- Non-501(c)(3) Nonprofits
- Special District Governments
- Small Businesses
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Private)
- For Profit Organizations
- Other
- City/Township Governments
- Higher Education Inst. (Public)
- 501(c)(3) Nonprofits
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Department of Health and Human Services National Institutes of Health is seeking applicants for the "Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)" grant opportunity. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identify targets for future development of prevention and treatment efforts. Eligible applicant types include a range of organizations such as government entities, nonprofits, higher education institutions, and small businesses. The application deadline is September 7, 2026, and the funding instrument is a grant.
The grant opportunity is funded under the Mental Health Research Grants program (CFDA 93.242). Details on award amounts or budget ranges are not provided in the announcement. The research activities are expected to be conducted at the facilities of the recipient organizations across the United States.
Synopsis
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-039-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity